D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 48.58M 44.58M 47.98M 106.46M 118.46M
Total Other Revenue -- -- -- -- --
Total Revenue 48.58M 44.58M 47.98M 106.46M 118.46M
Cost of Revenue 117.49M 130.55M 134.27M 91.19M 91.11M
Gross Profit -53.87M -70.92M -71.25M 15.26M 27.35M
SG&A Expenses 24.96M 24.61M 23.70M 23.08M 23.59M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 104.93M 117.64M 120.46M 107.56M 97.60M
Operating Income -56.36M -73.06M -72.48M -1.10M 20.86M
Income Before Tax -53.60M -69.76M -68.57M 3.61M 20.05M
Income Tax Expenses 0.00 0.00 0.00 97.00K 2.60M
Earnings from Continuing Operations -53.60 -69.76 -68.57 3.51 17.46
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -53.60M -69.76M -68.57M 3.51M 17.46M
EBIT -56.36M -73.06M -72.48M -1.10M 20.86M
EBITDA -56.36M -73.06M -72.39M -973.30K 21.10M
EPS Basic -0.98 -1.28 -1.27 0.08 0.34
Normalized Basic EPS -0.60 -0.79 -0.78 0.05 0.30
EPS Diluted -0.98 -1.28 -1.27 0.08 0.34
Normalized Diluted EPS -0.60 -0.79 -0.78 0.05 0.30
Average Basic Shares Outstanding 220.07M 218.00M 216.15M 214.61M 213.19M
Average Diluted Shares Outstanding 220.07M 218.00M 216.15M 214.72M 213.30M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --